Biohit OyjCHIX:BIOBVH 72 Forward Dividend Yield % is 0.00% as of Jul. 07, 2026. GuruFocus rates CHIX:BIOBVH with a GF Score™ of 72/100 and a GF Value™ of €2.44. The stock has 3 warning signs investors should review. Among 314 Medical Devices & Instruments companies, Biohit Oyj ranks worse than 318471.02% on this metric.
As of today (2026-07-07), the Forward Annual Dividend Yield of Biohit Oyj is 0.00%.
As of today (2026-07-07), the Trailing Annual Dividend Yield of Biohit Oyj is 0.00%.
CHIX:BIOBVh's Forward Dividend Yield % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.095 * Ranked among companies with meaningful Forward Dividend Yield % only.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
CHIX:BIOBVH vs ABT, SYK, MDT: Forward Dividend Yield % Comparison
For the Medical Devices subindustry, Biohit Oyj's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biohit Oyj Forward Dividend Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Biohit Oyj's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Biohit Oyj's Forward Dividend Yield % falls into.
What does a Forward Dividend Yield % of 0.00% mean?
Biohit Oyj (CHIX:BIOBVH) has a Forward Dividend Yield % of 0.00% as of Jul. 07, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Biohit Oyj and its competitors. According to the industry distribution chart, Biohit Oyj ranks #999999 out of 314 companies in the Medical Devices & Instruments industry.
Is Biohit Oyj's Forward Dividend Yield % too high?
Biohit Oyj's current Forward Dividend Yield % is 0.00%. Based on the distribution chart, Biohit Oyj ranks #999999 out of 314 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Biohit Oyj has a GF Score™ of 72/100, reflecting its overall financial health beyond just this single metric.
How does Biohit Oyj's Forward Dividend Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Biohit Oyj ranks #999999 out of 314 companies for Forward Dividend Yield %. This places Biohit Oyj in the lower half of its industry. The industry median Forward Dividend Yield % is 2.10. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Medical Devices & Instruments company?
The median Forward Dividend Yield % among Medical Devices & Instruments companies is 2.10, based on 314 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Biohit Oyj and its competitors. For the Medical Devices & Instruments industry, the median Forward Dividend Yield % is 2.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biohit Oyj's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biohit Oyj stock overvalued right now?
Biohit Oyj (CHIX:BIOBVH) has a current Forward Dividend Yield % of 0.00%. The stock's GF Value™ is €2.44, compared to a current price of €2.40 — trading 1.6% below its estimated fair value. The current Forward Dividend Yield % is 0.00%. Biohit Oyj's overall GF Score™ is 72/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Biohit Oyj (CHIX:BIOBVH), the current Forward Dividend Yield % is 0.00% as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Biohit Oyj (CHIX:BIOBVH) Overvalued in 2026?
Based on GuruFocus' analysis, Biohit Oyj stock appears to be undervalued.
The current stock price of €2.40 is trading 1.6% below its estimated GF Value™ of €2.44.
Key valuation signals for CHIX:BIOBVH:
Forward Dividend Yield %: 0.00%
GF Value™: €2.44 vs. price of €2.40 (1.6% below fair value)
No single metric tells the full story. See the CHIX:BIOBVH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Biohit Oyj is a globally operating Finnish biotechnology company that develops diagnostic and other health products. Its products include GastroPanel quick test assesses the structure and function of the stomach lining; ColonView quick test is an immunochemical fecal occult blood test (FIT) developed; Acetium capsules protect the stomach lining from carcinogenic acetaldehyde, especially in people with acid-free stomachs. The company's product portfolio consists of diagnostic tests, analysis systems, products binding carcinogenic acetaldehyde into a harmless compound and monoclonal antibodies.
72GF Score
Get the complete analysis for CHIX:BIOBVH
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:BIOBVH has been successfully added to your 